-+ 0.00%
-+ 0.00%
-+ 0.00%
According to the Zhitong Finance App, Tianshan Biotech (300313.SZ) announced that the company will sell 488 live animals in July 2026, with sales revenue of 5.8861 million yuan. Live animal sales decreased by 39.45% month-on-month, and revenue decreased by 44.28% month-on-month; sales increased 876% year over year, and revenue increased 1021.17% year over year. In July, the company adjusted the pace of cow release in due course based on comprehensive considerations such as market conditions and the growth cycle of cows, which led to a decline in month-on-month data; due to the low base for the same period last year, the year-on-year data still achieved growth. The above changes are normal cyclical adjustments.
Share
Listen to the news
According to the Zhitong Finance App, Tianshan Biotech (300313.SZ) announced that the company will sell 488 live animals in July 2026, with sales revenue of 5.8861 million yuan. Live animal sales decreased by 39.45% month-on-month, and revenue decreased by 44.28% month-on-month; sales increased 876% year over year, and revenue increased 1021.17% year over year. In July, the company adjusted the pace of cow release in due course based on comprehensive considerations such as market conditions and the growth cycle of cows, which led to a decline in month-on-month data; due to the low base for the same period last year, the year-on-year data still achieved growth. The above changes are normal cyclical adjustments.
Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.
What's Trending